| Name | Title | Contact Details |
|---|
Cydan Development is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential.
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body`s innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
Making lives better with natural botanical therapies derived from our patented extraction process
Aquatic Biotechnologies Inc is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
YmAbs has a powerful set of capabilities for the development of biologics. Our product development team includes some of the most talented and experienced professionals in the antibody industry.